Protalix BioTherapeutics, Inc (PLX) - NYSEMKT
From other sites
Company Description
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. Its... More
Sector: Healthcare
Industry: Biotechnology
Country: United States